Serum interleukin-17 as a novel biomarker in patients with acne vulgaris.
Adel A EbrahimAmany Ibrahim MustafaAwad Mohamed El-AbdPublished in: Journal of cosmetic dermatology (2019)
Serum IL-17 is not only a biomarker of disease pathogenesis but also it could be a potential prognostic predictor for severity and scarring in acne vulgaris.
Keyphrases